| Filed On | Filing |
|---|---|
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
Executive Vice President, Chief Financial Officer & Treasurer |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition
Executive Vice President, Chief Financial Officer & Treasurer |
| 24 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
As previously reported, on May 1, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”) and Ms. Mary Ann E. Moore determined that Ms. Moore would transition from her role as the Executive Vice President, General Coun... |
| 15 Jul 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Executive Vice President, Chief Financial Officer & Treasurer |
| 07 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
As disclosed under Item 5.07 of this Current Report on Form 8-K, at the 2026 Annual Shareholders’ Meeting (the “Annual Meeting”) of Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), held on May 7, 2026, the shareholde... |
| 05 May 2026 |
8-K: Results of Operations and Financial Condition
Executive Vice President, Chief Financial Officer & Treasurer |
| 19 Feb 2026 |
8-K: Results of Operations and Financial Condition
Executive Vice President, Chief Financial Officer & Treasurer |
| 03 Nov 2025 |
8-K: Results of Operations and Financial Condition
Executive Vice President, Chief Financial Officer & Treasurer |
| 18 Aug 2025 |
8-K: Regulation FD Disclosure; Other Events
Executive Vice President, Chief Financial Officer & Treasurer |
| 05 Aug 2025 |
8-K: Results of Operations and Financial Condition
Executive Vice President, Chief Financial Officer & Treasurer |
| 01 Jul 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Executive Vice President, Chief Financial Officer and Treasurer |
| 08 May 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On May 8, 2025, Pediatrix Medical Group, Inc., a Florida corporation (the "Company"), held its 2025 Annual Shareholders’ Meeting (the “Annual Meeting”). Of the 85,816,882 shares of common stock outstanding and entitled to vote, 77,889,78... |
| 06 May 2025 |
8-K: Results of Operations and Financial Condition
Executive Vice President, Chief Financial Officer & Treasurer |
| 18 Apr 2025 |
8-K: Entry into a Material Definitive Agreement
On April 15, 2025, PMG Services, Inc. (“PMG Services”), a Florida corporation and wholly-owned subsidiary of Pediatrix Medical Group, Inc., and Guidehouse Managed Services LLC, a Delaware limited liability company (“Guidehouse”), agreed ... |
| 20 Feb 2025 |
8-K: Results of Operations and Financial Condition
FORT LAUDERDALE, Fla., February 20, 2025 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, ... |
| 14 Jan 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Effective on January 12, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), appointed Mr. Mark S. Ordan to serve as the Company’s Chief Executive Off... |
| 13 Jan 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Executive Chair Mark S. Ordan to Return as Chief Executive Officer |
| 05 Dec 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
On December 5, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), and Dr. Curtis B. Pickert, the current Executive Vice President, Chief Physician Executive and former Chief Operating Officer of the Company, anno... |
| 01 Nov 2024 |
8-K: Results of Operations and Financial Condition
FORT LAUDERDALE, Fla., November 1, 2024 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.23 per share for the three months ended September 30, 2024. On a non-GAAP basis, ... |
| 06 Aug 2024 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
FORT LAUDERDALE, Fla., August 6, 2024 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported a loss of $1.84 per share for the three months ended June 30, 2024. On a non-GAAP basis, Pediatrix... |
Loading...